Asthma remission has emerged as a potential therapeutic goal. However, definitions of remission have primarily focused on adult populations, with lim…
Limited evidence suggests that airway epithelial structure and function is disrupted in very preterm infants; however, the epithelial morphology and…
The Wal-yan Respiratory Research Centre is thrilled to see three researchers awarded prestigious Medical Research Future Fund (MRFF) Chronic Respirat…
Asthma affects more than 300 million people worldwide and is frequently associated with other medical conditions in adults, including chronic obstruc…
Managing bronchiectasis exacerbations is a priority for patients, parents, and caregivers of children with bronchiectasis. However, evidence-based st…
Type 1 interferons (T1IFNs) are typically expressed in low concentrations under homeostatic conditions, but upon pathogenic insult or perturbation of…
Researchers developing a world-first treatment that targets an underlying cause of asthma have secured a $499,640 grant from the Future Health, Resea…
Dr Renee Ng, a microbiologist specialising in bacteriophage therapy – an alternative to antibiotics to fight antimicrobial resistance – will travel t…
Jack Canning, a PhD researcher in the Wal-yan Respiratory Centre’s Phage WA team, has made a significant finding in the search for alternative treatm…